Physician profile
Mitchell S Willcutt
NPI 1255371787
$1,379.88
in general payments reported to CMS, 2019-2025
14 companies · $733 in 2025
The $733 reported for 2025 was more than what 86% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $106 · 2022: $150 · 2023: $187 · 2024: $204 · 2025: $733.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,123.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,123.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Surgical Specialties Corporation (US), INC. (Dba Corza Medical) | $654.98 | 2024-2025 | |
| Medtronic, INC. | $235.06 | 2022-2024 | Avalus, Heli-Fx Endoanchor System, Mosaic |
| W. L. Gore & Associates, INC. | $121.89 | 2021-2025 | Gore Tag Conformable Thoracic Endoprosthesis, Gore Excluder Aaa Endoprosthesis |
| Baxter Healthcare | $72.29 | 2023 | Coseal, Ostene, Preveleak |
| Silk Road Medical, INC. | $60.49 | 2023-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Depuy Synthes Sales INC. | $48.21 | 2021-2022 | |
| Solventum Corporation | $34.60 | 2025 | Prevena, V.A.C. Veraflo |
| Edwards Lifesciences Corporation | $33.85 | 2021 | |
| Octapharma USA, INC. | $31.57 | 2025 | Fibryga |
| Elutia, INC. | $27.01 | 2022 | |
| Cvrx, INC. | $18.91 | 2022 | |
| Kls-Martin L.P. | $15.01 | 2023 | |
| Prime Surgical, LLC | $14.33 | 2025 | |
| Lsi Solutions INC | $11.68 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mitchell Willcutt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.